Sana Biotechnology logo

Sana Biotechnology

SANA | NASDAQ
Chart Builder DCF Calculator
$1.88
-$0.14 (-6.93%)
At close: Nov 16, 2026, 4:00 PM ET
$1.88
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:41 PM ET
-6.93%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
35.4
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #648/1021 (Top 63%)

Key Statistics

Market Data

Market Cap $563.31M
1D Range
1.87 2.02
52W Range
1.87 5.18

Valuation (TTM)

PE -3.62
PB 3.12
EV/EBITDA -3.45

Valuation (NTM)

Forward PE N/A
Forward PEG 0.10
Price Target $7.00
Loading financial charts...

Profile

Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range ...

Sector Healthcare
Industry Biotechnology
Employees 142
IPO Date Feb 4, 2021
Fiscal Year January - December

Latest News

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

2 months ago · prnewswire.com

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Sana Biotechnology to Present at September 2026 Investor Conferences

3 months ago · globenewswire.com

Sana Biotechnology to Present at September 2026 Investor Conferences
Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes

4 months ago · globenewswire.com

Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

9 months ago · globenewswire.com

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Sana Biotechnology to Present at March 2026 Investor Conferences

9 months ago · globenewswire.com

Sana Biotechnology to Present at March 2026 Investor Conferences
Sana Biotechnology: A Small, Speculative Play

9 months ago · seekingalpha.com

Sana Biotechnology: A Small, Speculative Play
Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know

10 months ago · zacks.com

Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know
Wall Street Analysts Think Sana (SANA) Could Surge 74.2%: Read This Before Placing a Bet

10 months ago · zacks.com

Wall Street Analysts Think Sana (SANA) Could Surge 74.2%: Read This Before Placing a Bet
Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips

10 months ago · seekingalpha.com

Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips
Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

10 months ago · seekingalpha.com

Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$7.00
Upside
+272.34%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.